Traditional Chinese Medicine: An Exogenous Regulator of Crosstalk between the Gut Microbial Ecosystem and CKD

X Sun, W Sun, Y Huang, J Chen - … ‐Based Complementary and …, 2022 - Wiley Online Library
Chronic kidney disease (CKD) is often accompanied by an imbalance in the gut microbial
ecosystem. Notably, the imbalanced gut microbiota and impaired intestinal barrier are the …

Network Pharmacology Analysis and Machine-Learning Models Confirmed the Ability of YiShen HuoXue Decoction to Alleviate Renal Fibrosis by Inhibiting Pyroptosis

MC Feng, F Luo, HM Wu, Y Chen, J Zuo… - Drug Design …, 2023 - Taylor & Francis
Purpose YiShen HuoXue decoction (YSHXD) is a formulation that has been used clinically
for the treatment of renal fibrosis (RF) for many years. We aimed to clarify therapeutic effects …

Association between consumption of flavonol and its subclasses and chronic kidney disease in US adults: an analysis based on National Health and Nutrition …

P Liu, L Tang, G Li, X Wu, F Hu, W Peng - Frontiers in Nutrition, 2024 - frontiersin.org
Background There is little research on the relationship between flavonol consumption and
chronic kidney disease (CKD). This study aimed to examine the link between flavonol …

An integrated study of Shenling Baizhu San against hyperuricemia: Efficacy evaluation, core target identification and active component discovery

Y Wang, Z Lin, J Huang, M Chu, X Ding, W Li… - Journal of …, 2022 - Elsevier
Abstract Ethnopharmacological relevance Shenling Baizhu San (SLBZ) is a famous
Traditional Chinese Medicine (TCM) formula that strengthens the spleen for replenishing qi …

[HTML][HTML] Qigui-Yishen decoction delays renal fibrosis in mice with chronic kidney disease by regulating TM and PAI-1

X Lu, XW Wan - American Journal of Translational Research, 2024 - ncbi.nlm.nih.gov
Objective: To explore the mechanism of Qigui-Yishen decoction in delaying renal fibrosis in
mice by regulating thrombin regulatory protein (Thrombomodulin, TM) and plasminogen …